CD8A and neoplasm: Furthermore, CD8+ depletion inhibited VEGF121/rGel-PCI enhanced αCTLA4-induced MC38 tumor reduction, and no animals experienced reduction in tumor volume following VEGF121/rGel-PCI enhanced αCTLA4 in the presence of an αCD8+ antibody (Figures 8F, S9F).